AMCON Distributing Co. - Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the first fiscal quarter (Q1) ended December 31, 2024. AMCON Distributing Co. operates two primary segments: a Wholesale Segment distributing consumer products (cigarettes, tobacco, confectionery, foodservice) to approximately 7,900 retail outlets across 34 states, and a Retail Segment operating 15 natural/organic health food stores. The company is a non-accelerated filer and smaller reporting company.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Sales | $711.3 million | $645.0 million |
| Gross Profit | $46.9 million | $43.3 million |
| Gross Margin | 6.6% | 6.7% |
| Operating Income | $3.7 million | $3.8 million |
| Net Income (Common) | $0.35 million | $1.07 million |
| Diluted EPS | $0.57 | $1.78 |
| Operating Cash Flow | ($39.9 million) used | $5.0 million provided |
| Total Debt (Credit Facilities) | $165.9 million | $121.3 million |
| Cash on Hand | $0.54 million | $0.67 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated sales increased 10.3% ($66.3 million). The Wholesale Segment drove this growth with a 10.5% increase, attributed to acquisitions (Burklund and Richmond Master), manufacturer price increases, and volume/mix changes in non-cigarette categories. The Retail Segment saw a slight 1.5% decline due to store closures.
- Profitability Decline: Net income dropped 67.5% to $0.35 million. This was primarily due to a $1.5 million non-cash gain in the prior year from a contingent consideration adjustment that did not recur, higher interest expenses ($0.5 million increase), and increased operating costs.
- Cash Flow Deterioration: Operating cash flow swung from a $5.0 million inflow to a $39.9 million outflow. This was driven by a significant increase in inventory levels ($30.3 million outflow) and reductions in accounts payable and accrued expenses.
- Debt Increase: Borrowings under credit facilities increased by approximately $44.6 million to fund acquisitions and working capital needs. Total available credit capacity remains at $305.0 million, with $81.6 million available at period end.
Outlook, Risks, and Unusual Items
- Unusual Items: The prior year included a $1.5 million gain from the revaluation of contingent consideration related to the Burklund acquisition. In Q1 2025, management determined the sales thresholds for this payout were not probable, resulting in the liability being written down to zero. This non-recurring gain significantly inflated prior-year earnings.
- Acquisitions: The company closed on the acquisition of Arrowrock Supply on January 17, 2025, for approximately $6.1 million in cash. Integration of Burklund and Richmond Master continues.
- Risks: Management highlights risks related to FDA regulations on tobacco/vaping products (including menthol bans), inflationary pressures on labor and fuel, supply chain disruptions, and potential customer credit risks. The company does not hedge interest rate or fuel cost exposure.
- Dividends: A regular dividend of $0.18 per share was paid. A special dividend of $0.28 per share was declared in Q1 2025 and is accrued for payment in Q2 2025.
Investor Verification Checklist
- Inventory Build: Verify the sustainability of the $30.3 million increase in inventory and its impact on future working capital requirements.
- Recurring Earnings: Assess core profitability excluding the one-time $1.5 million contingent consideration gain from the prior year to understand true operational trends.
- Debt Covenants: Confirm compliance with financial covenants given the increased debt load and interest rate environment (average rate 5.96%).
- Regulatory Exposure: Monitor FDA proposals regarding menthol and vaping products, which could materially impact the Wholesale Segment's revenue mix.
- Acquisition Integration: Track the performance and integration progress of the Burklund, Richmond Master, and Arrowrock acquisitions.